Chemicals and antibodies; Plasmid and lentiviral constructs; Immunoprecipitation and Western blotting; qPCR; ChIP assay; Immunofluorescence. (DOCX 22 kb
Immunopositivity for stem cell reprogramming factors in malignant and benign vascular tumors. Table ...
Detailed methods: lentiviral production and transduction, metabolic assays, and list of reagents for...
Table S1. Details of the antibodies and immunohistochemistry protocols employed. (DOCX 17 kb
Table S1. Main characteristics of the US Patients and Normal donors cohort. Table S2. Main character...
Figure S3. MM Gfi1 o/e cells produce higher levels of osteoclastogenic factors. MM.1S EV and Gfi1 o/...
Figure S2. Gfi1 overexpression increases metabolic activity and confers protection from Btz-induced ...
Figure S1. Gfi1-KD induces apoptosis in MM cells regardless of their p53 status. MM.1S cells, lentiv...
Figure S1. Evaluation by quantitative Real Time PCR of mRNA expression of AREG in HMCLs (A) and in M...
Figure S1. (A) Relative transcriptional levels of MIF expression in B cells, T cells, non-malignant ...
Figure S1. An antibody microarray to test the level of the growth factors derived from the hAMSCs. (...
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Figure S2. Schematic representation of the role of MM-exosomes in bone microenvironment. (TIF 3372 k...
Figure S4. a Double-staining Immunofluorescence detection showing TRPV2 (red) and CD38 (green) in A5...
Figure S2. a-j Point graph depicting the levels of TRPV2â6 mRNA in MM patients BM plasma cells fro...
Figure S1. Characterization of MSCs isolated from bone marrow of Syrian golden hamster. Immunophenot...
Immunopositivity for stem cell reprogramming factors in malignant and benign vascular tumors. Table ...
Detailed methods: lentiviral production and transduction, metabolic assays, and list of reagents for...
Table S1. Details of the antibodies and immunohistochemistry protocols employed. (DOCX 17 kb
Table S1. Main characteristics of the US Patients and Normal donors cohort. Table S2. Main character...
Figure S3. MM Gfi1 o/e cells produce higher levels of osteoclastogenic factors. MM.1S EV and Gfi1 o/...
Figure S2. Gfi1 overexpression increases metabolic activity and confers protection from Btz-induced ...
Figure S1. Gfi1-KD induces apoptosis in MM cells regardless of their p53 status. MM.1S cells, lentiv...
Figure S1. Evaluation by quantitative Real Time PCR of mRNA expression of AREG in HMCLs (A) and in M...
Figure S1. (A) Relative transcriptional levels of MIF expression in B cells, T cells, non-malignant ...
Figure S1. An antibody microarray to test the level of the growth factors derived from the hAMSCs. (...
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Figure S2. Schematic representation of the role of MM-exosomes in bone microenvironment. (TIF 3372 k...
Figure S4. a Double-staining Immunofluorescence detection showing TRPV2 (red) and CD38 (green) in A5...
Figure S2. a-j Point graph depicting the levels of TRPV2â6 mRNA in MM patients BM plasma cells fro...
Figure S1. Characterization of MSCs isolated from bone marrow of Syrian golden hamster. Immunophenot...
Immunopositivity for stem cell reprogramming factors in malignant and benign vascular tumors. Table ...
Detailed methods: lentiviral production and transduction, metabolic assays, and list of reagents for...
Table S1. Details of the antibodies and immunohistochemistry protocols employed. (DOCX 17 kb